Filing Flows › Steris (STE) › Q2 FY26
Steris (STE) Q2 FY26 earnings results (second quarter fiscal 2026)
10-Q filed Nov 6, 2025
Steris (STE) reported revenue of $1.5B for the second quarter fiscal 2026 (Q2 FY26), +10% from a year earlier and +5% from the quarter before. Operating margin was 18.2%, net earnings $192M (13.2% of revenue).
Steris, Q2 FY26: revenue $1.5B (+10% year over year), operating margin 18.2%, net earnings $192M, operating cash flow $288M. The chart follows the revenue to costs, profit and cash.
| Q2 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5B | +5% | +10% |
| Gross profit | $646M | +3% | +12% |
| Operating profit | $266M | +8% | +21% |
| Net earnings | $192M | +8% | +27% |
| Operating cash flow | $288M | -31% | +15% |
| Free cash flow | $201M | -38% | +35% |
What changed
Revenue was $1.5B in Q2 FY26, up 10% year over year and up 5% from the previous quarter. Healthcare was the largest line at 71% of revenue. Healthcare added $0.09B year over year (up 9%), 68% of the total change.
Gross margin was 44.2%, up 0.7 points from a year earlier. Operating profit was $0.27B, a 18.2% margin (up 1.7 points year over year). Of the extra revenue versus a year earlier, 35% reached operating profit, above the 17% margin then. Operating expenses grew 6% against revenue growth of 10%. Net earnings were $0.19B, up 28% year over year. The effective tax rate was 23.9%.
Operating cash flow was $0.29B (up 15% year over year), 150% of net earnings. Non-cash charges added back $0.12B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.05B. Capital expenditures of $0.09B left free cash flow of $0.20B.
Questions
What was Steris' revenue in the second quarter fiscal 2026?
Steris (STE) reported revenue of $1.5B for the second quarter fiscal 2026 (Q2 FY26), +10% from a year earlier and +5% from the quarter before.
Was Steris profitable in the second quarter fiscal 2026?
Operating profit was $266M (18.2% of revenue) and net earnings $192M.
Source: Steris 10-Q on SEC EDGAR.